Alzheimer's disease & dementia

Alzheimer's: Nicotinic receptors as a new therapeutic target

Several scientific studies have indicated that nicotine may be beneficial for memory function. Scientists from the Institut Pasteur and the CNRS set out to shed further light on the properties attributed to nicotine - which ...

Alzheimer's disease & dementia

Study reveals new link between Down syndrome and Alzheimer's

Individuals with Down syndrome who survive into adulthood face the additional challenge of early-onset dementia, in which toxic amyloid plaques build up in the brain. The condition is strikingly similar to Alzheimer's disease, ...

Alzheimer's disease & dementia

Enzyme BACE1 may be important in predicting onset of Alzheimer disease

The critical enzyme beta-secretase1 (BACE1) is known to be elevated in brains with sporadic Alzheimer disease (AD). Scientists have now found increased levels of BACE1 in brains with mild cognitive impairment (MCI), suggesting ...

Medical research

Road block as a new strategy for the treatment of Alzheimer's

Blocking a transport pathway through the brain cells offers new prospects to prevent the development of Alzheimer's. Wim Annaert and colleagues of VIB and K.U. Leuven discovered that two main agents involved in the inception ...

Medical research

Natural Alzheimer's weapon suggests better treatment

Scientists have shown a molecular chaperone is working like a waste management company to collect and detoxify high levels of toxic amyloid beta peptide found in Alzheimer's disease.

page 2 from 2